Anti-CCR5/CXCR4 sheep monoclonal antibody - KS Biomedix Holdings

Drug Profile

Anti-CCR5/CXCR4 sheep monoclonal antibody - KS Biomedix Holdings

Alternative Names: Anti-CCR5/CXCR4; Anti-CCR5/CXCR4 MAb

Latest Information Update: 27 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator KS Biomedix Holdings; Nonindustrial source
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action CCR5 receptor antagonists; CXCR4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 27 Sep 2002 Discontinued - Preclinical for HIV-1 infections in France (unspecified route)
  • 27 Sep 2002 Discontinued - Preclinical for HIV-1 infections in United Kingdom (unspecified route)
  • 19 Oct 2000 Anti-CCR5/CXCR4 sheep monoclonal antibodies are available for licensing (http://www.ksbiomedix.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top